Minimal Residual Disease
Monitoring Tumor Burden
Biomarkers of sensitivity to
treatments
Biomarkers of resistance to
treatments
A comprehensive panel is required for many applications: NGS based
T
N
•
Gene-panel
capture
approaches (up
to 24000 genes)
•
Exome-seq
(24000 genes)
•
Whole genome
sequencing
•
Amplicon-seq
(up to 200
genes)